Graham G. Walmsley Insider Trading Activity (OLMA)

Summary

Updated Jul 16, 2026

Graham G. Walmsley has filed 1 SEC Form 4 filing across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $4.73M. Lifetime open-market sales: $4.73M.

Role	Insider
Notability	20/100

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2025-12-09	AKRO	Akero Therapeutics, Inc.	D — Derivative transaction	9.4K	—
2025-12-09	AKRO	Akero Therapeutics, Inc.	D — Derivative transaction	1.20M	—
2025-12-09	AKRO	Akero Therapeutics, Inc.	D — Derivative transaction	93.0K	—
2025-10-08	AKRO	Akero Therapeutics, Inc.	M — Option exercise	23.8K	$19.97	$476K
2025-10-08	AKRO	Akero Therapeutics, Inc.	M — Option exercise	13.0K	$25.20	$328K
2025-10-08	AKRO	Akero Therapeutics, Inc.	M — Option exercise	13.0K	$26.32	$342K
2025-10-08	AKRO	Akero Therapeutics, Inc.	M — Option exercise	15.0K	$8.13	$122K
2025-10-08	AKRO	Akero Therapeutics, Inc.	M — Option exercise	26.0K	$23.02	$599K
2024-12-17	OLMA	Olema Pharmaceuticals, Inc.	P — Open-market purchase	700.8K	$6.75	$4.73M
2024-12-17	OLMA	Olema Pharmaceuticals, Inc.	S — Open-market sale	700.8K	$6.75	$4.73M

Frequently Asked Questions

Who is Graham G. Walmsley?

Graham G. Walmsley is a corporate insider — currently tracked as Insider of Olema Pharmaceuticals, Inc. (OLMA). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Graham G. Walmsley submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Graham G. Walmsley been buying or selling stock?

Recorded transactions: 1 open-market purchases ($4.73M) and 1 open-market sales ($4.73M) across all tracked filings.

Where can I see all of Graham G. Walmsley's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Graham G. Walmsley — SEC Form 4 Insider Trading Activity

Summary

Profile

Board memberships